Plain-English translation of NCT07265284 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a medication called can help treat moderate to severe plaque psoriasis in teenagers. Half of the participants will receive the new medication for the entire 44-week study, while the other half will first receive a placebo (a dummy treatment with no active ingredient) for 16 weeks, then switch to the medication for the remaining weeks. Researchers want to see if this treatment is safe and effective for young people with psoriasis.
Psoriasis can be painful and emotionally difficult, especially for teenagers, and current treatment options don't work well enough for everyone. This trial is testing whether this medication could offer teenagers a new, safer, and more effective way to manage their psoriasis.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will visit the clinic regularly over 44 weeks (about 11 months). You will either receive the new medication right away or receive a placebo first, then switch to the medication midway through. At each visit, doctors will check how your skin is responding, ask about any side effects, and do blood tests to make sure the treatment is safe. The study is double-blind, which means neither you nor your doctor will know at first whether you're getting the real medication or placebo.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China